Abstract
In Chapter 9 of the revised PIC/S GMP Annex 1 (issued in September 2022), the requirements for environmental monitoring were substantially updated and redefined as a critical quality system element supporting the Contamination Control Strategy (CCS). However, the specific methodologies for risk assessment and operational design approaches are largely left to the discretion of individual manufacturers. As a result, practical decisions must be made at the manufacturing site regarding monitoring locations, monitoring frequency, incubation conditions, alert and action limits, and the scope of microbial identification.
This paper outlines the key challenges associated with establishing environmental monitoring programs and, based on discussions from the “PDA Japan Chapter’s PIC/S GMP Annex 1 Workshop Series I (EM ed.)”, presents practical approaches to risk assessment, program design, and rationalization aligned with the intent of Annex 1. Environmental monitoring should operate as a continuous PDCA (Plan-Do-Check-Action) cycle and should not be the objective but rather function as an effective tool to support sterility assurance. The path forward is clear: the integration of scientifically sound and risk-based practices, including the adoption of rapid microbiological methods (RMM), will be essential to meet evolving industry demands.
